Published in Br J Clin Pharmacol on August 01, 1975
Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol (1977) 1.90
Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest (1950) 9.22
Predisposing factors in adverse reactions to drugs. Br Med J (1969) 5.80
Effect of age and sex on human drug metabolism. Br Med J (1971) 5.19
Digoxin metabolism in the elderly. Circulation (1969) 2.56
The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol (1975) 2.28
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther (1973) 2.14
VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE. Biochem Pharmacol (1964) 2.07
Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding. Br J Clin Pharmacol (1975) 1.76
Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteins. Br J Clin Pharmacol (1975) 1.46
Effect of age on intestinal absorption: implications for drug absorption in the elderly. J Am Geriatr Soc (1968) 1.17
Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice. Br Med J (1972) 1.12
Pharmacodynamic consequences of aging and their implications in the treatment of the elderly patient. Med Ann Dist Columbia (1967) 0.93
The effect of ageing on plasma pethidine concentration. Br J Clin Pharmacol (1975) 0.82
[Effect of barbiturates on rats of different ages]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.81
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J (1966) 2.31
Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy. Lancet (1970) 1.96
Selective pharmacological inhibition of lymphocyte stimulation. Lancet (1971) 1.62
Absorption of propranolol and practolol in Coeliac disease. Gut (1976) 1.55
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography. Cancer Chemother Pharmacol (1978) 1.22
Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Br J Clin Pharmacol (1979) 1.11
An assessment of beta-adrenoceptor blockade in man by SK & F 92657, a new drug with combined vasodilator and beta-adrenoceptor blocking actions, and comparison with propranolol [proceedings]. Br J Clin Pharmacol (1980) 1.09
Suicidal chlorate poisoning treated with peritoneal dialysis. Br Med J (1967) 1.08
The problem of drug hypersensitivity. Guys Hosp Rep (1971) 0.91
Malabsorption of prednisolone from enteric-coated tablets after ileostomy. Br Med J (1980) 0.91
Additives to intravenous fluids. Br Med J (1976) 0.91
Ganglion cells in achalasia of the cardia. Virchows Arch A Pathol Anat Histol (1976) 0.85
Peritoneal dialysis in hypercatabolic acute renal failure. Lancet (1967) 0.85
Continuing education in clinical pharmacology. Proc R Soc Med (1968) 0.85
Hodgkin's disease and the liver. Guys Hosp Rep (1973) 0.84
The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy. Br J Clin Pharmacol (1980) 0.83
Antiemetics and cytotoxic drugs. Br Med J (Clin Res Ed) (1983) 0.82
Rosette formation in Hodgkin's disease. Oncology (1974) 0.82
Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites. Eur J Clin Pharmacol (1981) 0.81
The effect of single doses of amylobarbitone sodium and carbamazepine in tinnitus. J Laryngol Otol (1981) 0.80
The kinetics of salivary elimination of cyclophosphamide in man. Br J Clin Pharmacol (1979) 0.79
The effect of age on the hydroxylation of amylobarbitone sodium in man. Br J Clin Pharmacol (1974) 0.79
A rapid gas chromatographic method for the determination of plasma polyamines and its application to the prediction of tumour response to chemotherapy. Clin Chim Acta (1981) 0.79
Dosage and the pharmacokinetics of cytotoxic drugs. Br J Clin Pharmacol (1979) 0.79
An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride. Br J Clin Pharmacol (1982) 0.79
Calcium concentration in the kidney. Nephron (1968) 0.76
Plasma dopa concentrations after different preparations of levodopa in normal subjects. Br J Clin Pharmacol (1976) 0.76
Propranolol absorption in Crohn's disease and coeliac disease. Br Med J (1977) 0.75
The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease. Br J Clin Pharmacol (1977) 0.75
Letter: Infections after splenectomy in Hodgkins's disease. Br Med J (1976) 0.75
Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen. Br J Clin Pharmacol (1978) 0.75
Lymphocyte transformation. Br Med J (1971) 0.75
Antiemetic effect of nonabine in cancer chemotherapy: a double blind study comparing nonabine and chlorpromazine. Br Med J (Clin Res Ed) (1983) 0.75
Distribution and pharmacokinetics of cyclophosphamide in the rat. Br J Cancer (1980) 0.75
Metabolic changes following prolonged cardio-pulmonary by-pass. Guys Hosp Rep (1965) 0.75
First pass hepatic metabolism of cyclophosphamide [proceedings]. Br J Clin Pharmacol (1979) 0.75
Fat malabsorption associated with bacterial colonization of a colon transplant: a case report. Guys Hosp Rep (1973) 0.75
The effect of various diuretics on the excretion and concentration within the kidney of sodium and calcium. Int J Clin Pharmacol (1972) 0.75
Effect of vinblastine and mustine on the distribution of T and B-lymphocytes. Br J Pharmacol (1977) 0.75
Calcium uptake by kidney tissue slices. Nephron (1968) 0.75
Bullous pyoderma gangrenosum and multiple myeloma. Br J Dermatol (1984) 0.75
The effects of a Lundh meal on the plasma concentration/time curve of ampicillin, amoxycillin, pivampicillin and cephalexin in normal subjects [proceedings]. Br J Clin Pharmacol (1977) 0.75
Peritoneal dialysis in renal failure. Lancet (1967) 0.75